Your session is about to expire
← Back to Search
TMS for Smoking Cessation in Schizophrenia
Study Summary
This trial is testing whether transcranial magnetic stimulation can help people with schizophrenia quit smoking.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have a condition that increases my risk of seizures.I am between 22 and 65 years old.I have had a head injury with unconsciousness for over 10 minutes or brain surgery.I am currently seeing a doctor or mental health professional.I have a close family member with inherited epilepsy or seizures.I have tried to quit smoking in the last four weeks.I have a cardiac pacemaker, medication pump, intracardiac lines, or unstable heart condition.I take more than 400 mg of clozapine daily or I did not pass the TMS screening.I am not pregnant and have used birth control consistently for the last 4 weeks.I do not have any major illnesses that affect my brain's functioning.I am between 18 and 60 years old.You have smoked within the past year and have been smoking an average of 5 or more cigarettes per day in the past 4 weeks.You have smoked cigarettes regularly within the past year, and you smoke at least 5 cigarettes a day in the last 4 weeks.You are diagnosed with schizophrenia-spectrum disorder and you are over the age of 18.
- Group 1: Study group
- Group 2: Active control group
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is it possible to partake in this experiment?
"This medical trial is recruiting 50 individuals with schizophrenia, aged 18 to 60. Those who apply need to fulfil the following prerequisites: gender-neutrality, capacity for written consent, smoking over a year or more at 5 cigarettes per day in the last 4 weeks, clinically diagnosed schizoprenia-spectrum disorder and an Evaluation to Sign Consent score above 10."
To what extent can this research be conducted with participants?
"Affirmative. Clinicaltrials.gov attests that this trial is actively recruiting; the details of which were initially posted on June 1st 2022, and updated most recently on November 15th 2022. The study calls for 50 individuals to be recruited at one medical centre."
Are participants aged 50 and over accepted for this research endeavor?
"The age requirement to be eligible for this medical trial is between 18 and 60 years old."
Are participants still being accepted for this research endeavor?
"Indeed, clinicaltrials.gov verifies that this medical trial is actively recruiting patients since it was first published on June 1st 2022 and updated most recently in November 15th 2022. The research necessitates the recruitment of 50 individuals from a single site."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
How responsive is this trial?
Average response time
- < 2 Days
Typically responds via
Most responsive sites:
- University of Texas, Houston: < 24 hours
- University of Maryland, Baltimore: < 48 hours
Share this study with friends
Copy Link
Messenger